Huawei can’t block Samsung China manufacturing: US court
A US federal court in San Francisco says Samsung Electronics can continue manufacturing, selling smartphones in China while it battles Huawei Technologies over patent royalties
Washington/San Francisco: Samsung Electronics Co. can continue manufacturing and selling smartphones in China while it battles Huawei Technologies Co. over patent royalties, a US judge ruled.
The order by a federal judge in San Francisco blocks Huawei from enforcing a decision by a Chinese court, which ruled Samsung is infringing two Huawei patents.
In January, the Intermediate People’s Court of Shenzhen barred Samsung affiliates from manufacturing and selling the company’s 4G LTE standardized smartphones in China. Samsung is appealing. But the US judge said the Chinese ruling can’t take effect until he rules on a breach of contract claim filed in San Francisco.
China is the world’s biggest smartphone market. Samsung has argued that if the ruling banning the sale of LTE-enabled phones stands, it will have to close its factories in China. Huawei is China’s biggest maker of phones and network gear, while South Korea-based Samsung is the world’s largest maker of smartphones and semiconductors.
The order from the Chinese court “could render meaningless the proceedings here, and the risk of harm to Samsung’s operations in China in the interim is great,”’ US District Court Judge William H. Orrick wrote in Friday’s ruling.
Michael J. Bettinger, a lawyer for Huawei in San Francisco, didn’t immediately respond to a call and an email on Monday seeking comment on the ruling.
The case is Huawei Technologies Co. v. Samsung Electronics Co., 16-cv-02787, US District Court, Northern District of California (San Francisco). Bloomberg
- Barista in advanced talks with Swiggy, another player for food delivery
- Insurance startup Turtlemint raises $25 million from Sequoia, Nexus, Blume Ventures
- India to bar private refiners from tapping Iran oil quota
- Snapdeal partners with RBL, Federal Bank to penetrate non-metro markets
- Cabinet approves ₹6,000 crore capital infusion in Exim Bank
Editor's Picks »
- Why Tata Motors’ Project Charge at JLR is failing to recharge its shares
- Outlook on global profit growth worst since 2008 financial crisis
- Q3 results: ICICI Securities loses its retail broking crown
- High drug approvals to keep up pricing pressure for pharma firms
- Roads sector: Toll collections set to surge, but risks loom for developers